Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Short-course azithromycin no benefit in pediatric asthma admissions

Key clinical point: A 3-day course of azithromycin for children hospitalized with asthma does not shorten length of stay or bring other benefits.

Major finding: LOS was 1.86 days in the placebo arm, and 1.69 days in the azithromycin group (P = .23).

Study details: Randomized, placebo-controlled trial of 159 children.

Disclosures: There was no external funding, and the senior investigator had no disclosures.

Citation:

REPORTING FROM PHM 2019